Civitas gets $38M investment to advance treatment of Parkinson’s disease complications | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it
Just three months after receiving a receiving a $1 million grant from the Michael J. Fox Foundation, Civitas Therapeutics Wednesday said it landed $38 million in Series B financing.